Tower Research Capital (TRC)’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $980K | Buy |
18,369
+16,727
| +1,019% | +$893K | 0.03% | 557 |
|
|
2025
Q1 | $66.5K | Sell |
1,642
-14,546
| -90% | -$589K | ﹤0.01% | 2020 |
|
|
2024
Q4 | $450K | Buy |
16,188
+14,329
| +771% | +$399K | 0.01% | 1146 |
|
|
2024
Q3 | $53.3K | Sell |
1,859
-13,783
| -88% | -$395K | ﹤0.01% | 2687 |
|
|
2024
Q2 | $367K | Buy |
15,642
+14,758
| +1,669% | +$346K | 0.01% | 1592 |
|
|
2024
Q1 | $22.3K | Sell |
884
-3,060
| -78% | -$77.3K | ﹤0.01% | 2904 |
|
|
2023
Q4 | $92.1K | Buy |
3,944
+2,898
| +277% | +$67.7K | ﹤0.01% | 2713 |
|
|
2023
Q3 | $52.9K | Sell |
1,046
-952
| -48% | -$48.2K | ﹤0.01% | 2503 |
|
|
2023
Q2 | $93.3K | Sell |
1,998
-1,937
| -49% | -$90.4K | ﹤0.01% | 2054 |
|
|
2023
Q1 | $150K | Buy |
3,935
+1,802
| +84% | +$68.7K | ﹤0.01% | 1535 |
|
|
2022
Q4 | $116K | Buy |
2,133
+1,102
| +107% | +$59.9K | ﹤0.01% | 1715 |
|
|
2022
Q3 | $35K | Sell |
1,031
-7,136
| -87% | -$242K | ﹤0.01% | 3464 |
|
|
2022
Q2 | $77K | Sell |
8,167
-14,891
| -65% | -$140K | ﹤0.01% | 2493 |
|
|
2022
Q1 | $328K | Buy |
23,058
+21,305
| +1,215% | +$303K | ﹤0.01% | 1426 |
|
|
2021
Q4 | $37K | Sell |
1,753
-38
| -2% | -$802 | ﹤0.01% | 3013 |
|
|
2021
Q3 | $40K | Sell |
1,791
-961
| -35% | -$21.5K | ﹤0.01% | 3123 |
|
|
2021
Q2 | $68K | Buy |
2,752
+1,868
| +211% | +$46.2K | ﹤0.01% | 2757 |
|
|
2021
Q1 | $26K | Sell |
884
-2,922
| -77% | -$85.9K | ﹤0.01% | 3665 |
|
|
2020
Q4 | $98K | Buy |
3,806
+2,228
| +141% | +$57.4K | ﹤0.01% | 2364 |
|
|
2020
Q3 | $49K | Buy |
1,578
+36
| +2% | +$1.12K | ﹤0.01% | 3546 |
|
|
2020
Q2 | $38K | Buy |
1,542
+860
| +126% | +$21.2K | ﹤0.01% | 3257 |
|
|
2020
Q1 | $14K | Sell |
682
-2,367
| -78% | -$48.6K | ﹤0.01% | 1866 |
|
|
2019
Q4 | $68K | Buy |
+3,049
| New | +$68K | 0.01% | 1145 |
|
|
2019
Q3 | – | Sell |
-1,381
| Closed | -$26K | – | 4044 |
|
|
2019
Q2 | $26K | Buy |
+1,381
| New | +$26K | ﹤0.01% | 1992 |
|